Vivo Capital IX, LLC's Net Worth

$457 Million

Estimate Recalculated Feb 16, 2024 06:26PM EST

Who is Vivo Capital IX, LLC?

Vivo Capital IX, LLC has an estimated net worth of $457 Million. This is based on reported shares across multiple companies, which include Instil Bio, Inc., Tarsus Pharmaceuticals, Inc., ALX ONCOLOGY HOLDINGS INC, IO Biotech, Inc., and Sierra Oncology, Inc..

SEC CIK

Vivo Capital IX, LLC's CIK is 0001750698

Past Insider Trading and Trends

2020 was Vivo Capital IX, LLC's most active year for acquiring shares with 9 total transactions. Vivo Capital IX, LLC's most active month to acquire stocks was the month of December. 2022 was Vivo Capital IX, LLC's most active year for disposing of shares, totalling 13 transactions. Vivo Capital IX, LLC's most active month to dispose stocks was the month of June. 2022 saw Vivo Capital IX, LLC paying a total of $29,684,168.40 for 1,412,437 shares, this is the most they've acquired in one year. In 2022 Vivo Capital IX, LLC cashed out on 7,559,588 shares for a total of $214,552,826.06, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Sierra Oncology, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-3.33M
$55.00
-$183,123,160.00
0
Jul 1
Form 4
+41.33%
800K
$27.00
$21,600,000.00
2.74M
Jan 31
Form 4
+31.95%
612.44K
$13.20
$8,084,168.40
2.53M
Jan 26
Form 4
+3,045.01%
1.86M
1.92M
Jan 29
Form 3
0
0
No matching records found

ALX ONCOLOGY HOLDINGS INC (ALXO) Snapshot price: $15.54

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
4.22M
$19.00
$3,524,994.00
4.22M
Jul 21
Form 3
0
0
No matching records found

IO Biotech, Inc. (IOBT) Snapshot price: $1.7708

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
3.16M
$1.90
$5,999,998.60
3.16M
Aug 9
Form 4
3.02M
$14.00
3.02M
Nov 9
Form 3
0
0
No matching records found

Instil Bio, Inc. (TIL) Snapshot price: $11.94

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
12.49M
$20.00
12.49M
Mar 23
Form 3/A
0
0
Form 3
0
0
No matching records found

Tarsus Pharmaceuticals, Inc. (TARS) Snapshot price: $29.72

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-0.22%
-5.37K
$12.25
-$65,831.50
2.47M
May 5
Form 4
-17.17%
-512.96K
$13.39
-$6,866,310.96
2.47M
May 2 - May 4
Form 4
-1.83%
-55.68K
$29.79
-$1,658,842.40
2.99M
Jun 23 - Jun 25
Form 4
-6.21%
-201.62K
$29.05
-$5,856,114.00
3.04M
Jun 21 - Jun 22
Form 4
-0.01%
-400.00
$30.37
-$12,148.00
3.24M
Apr 14
Form 4
3.25M
$16.00
3.25M
Oct 20
Form 3
0
0
No matching records found